Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

138.62
-0.3700-0.27%
Post-market: 138.11-0.5100-0.37%19:58 EDT
Volume:2.37M
Turnover:327.92M
Market Cap:264.49B
PE:20.96
High:139.11
Open:138.76
Low:137.37
Close:138.99
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.58
T/O Rate:0.13%
Dividend:4.67
Dividend Rate:3.37%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.37
PE(LYR):19.39

Loading ...

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
Yesterday

NYSE Order Imbalance 99880.0 Shares on Sell Side

THOMSON REUTERS
·
Yesterday

Novartis AG Rises Monday, Outperforms Market

Dow Jones
·
Yesterday

Movement Alert|Novartis AG Rises 3.19% in Regular Trading, Major Shareholder Pushes for Board Overhaul as Analysts Upgrade Rating

Market Focus
·
Sep 14

Movement Alert|Novartis AG Rises 3.04% in Pre-Market Trading, Major Shareholder Pushes for Board Overhaul as Brokerages Upgrade Ratings

Market Focus
·
Sep 14

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

Novartis: More Pain on the Way?

Dow Jones
·
Sep 12

Novartis AG Falls Friday, Underperforms Market

Dow Jones
·
Sep 12

Novartis Needs to Make Progress on Pipeline to Justify Valuation

Dow Jones
·
Sep 11

Novartis shareholder calls for board changes, Reuters reports

TIPRANKS
·
Sep 10

Market Chatter: Novartis Shareholder Urges Board Changes After Trial Failures

MT Newswires Live
·
Sep 10

Novartis India Hits Record High After Recent Acquisition, Distribution Deal

Reuters
·
Sep 10

Novartis AG Falls Wednesday, Outperforms Market

Dow Jones
·
Sep 10

Dyne Therapeutics Myotonic Dystrophy Approach Remains Differentiated, RBC Says

MT Newswires Live
·
Sep 09

Novartis Shouldn't Rush to Cover Upcoming Patent Expirations

Dow Jones
·
Sep 09

RBC Initiates Novartis at Sector Perform With CHF120 Price Target

MT Newswires Live
·
Sep 09

Novartis's Stock Selloff Looks Overdone

Dow Jones
·
Sep 09

Novartis Faces Sales Hole in Early 2030s After Trial Setback

Dow Jones
·
Sep 09

Amgen Shares Plunge to Decade Low After Rival Drug Trial Fails, BMO Cuts Rating

Stock News
·
Sep 09

European Shares Steady as Drugmaker Rout Offsets Commodity Strength

Deep News
·
Sep 09